Engine Biosciences and Experimental Drug Development Centre Partner to Advance Novel Therapies to Combat Cancer
Apr 08, 2025
Singapore, April 8: Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medicine for cancer, announced a new partnership with the Experimental Drug Development Centre (EDDC), Singapore's national platform for drug discovery and development hosted by the Agency for Science, Technology and Research (A*STAR). This marks the first-ever collaboration between Engine Biosciences and Experimental Drug Development Centre (EDDC), Singapore's national platform for drug discovery and development . The partnership will advance the development of first-in-class precision therapeutics for multiple cancer types that are highly prevalent in Singapore and globally, including breast, liver, kidney and prostate cancers.